Vimarsana
Biggest News Aggregation in the World

Page 41 - Eric Domingo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Domingo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Domingo Today - Breaking & Trending Today

Philippines extends sympathies to Britain on Prince Philip's death; suspends use of AstraZeneca jab for people under 60 - Vimarsana News

Philippines extends sympathies to Britain on Prince Philip's death; suspends use of AstraZeneca jab for people under 60

Health workers sort patients' files at a triage area in Santa Ana Hospital, where a sign indicating that the hospital's coronavirus disease (Covid-19) facility is at full capacity is displayed, in Manila, Philippines, on April 9, 2021. - Reuters MANILA, April 10 (dpa): Philippine President Rodrigo Duterte expressed "deep condolences" on the passing of Prince Philip, as he cited the strong bilateral ties between the Philippines and Britain. "On behalf of the Filipino people, President Rodrigo Roa Duterte extends his deep condolences to Her Majesty Queen Elizabeth II on the pass...

FDA chief: Special use permit for ivermectin is issued per patient - Vimarsana News

FDA chief: Special use permit for ivermectin is issued per patient

By HANA BORDAY , GMA News Published April 10, 2021 12:24pm The Food and Drugs Administration on Saturday said that the compassionate special permit for the use of anti-parasitic drug ivermectin as COVID-19 treatment is issued per patient. In an interview with "Dobol B TV," FDA director general Eric Domingo explained that an application is needed before the regulatory body can issue the compassionate special permit to a hospital. “Lahat po ‘yan bawat ospital kumukuha ng compassionate special permit kasi kontrolado po sa CSP kung ilang tableta, kung kaninong pasyente nila gagamitin, ...

No ivermectin clinical trial vs. COVID-19 — DOST - Vimarsana News

No ivermectin clinical trial vs. COVID-19 — DOST

(FILE PHOTO) Metro Manila (CNN Philippines, April 10) — The government has no plans of conducting a clinical trial to determine if the anti-parasitic drug ivermectin works against COVID-19 as there are dozens of similar studies either completed or being conducted in other parts of the world, the Department of Science and Technology said Friday. “(With) almost 20 completed and 40 ongoing clinical trials around the world as reported in clinicaltrials.gov exploring the use of Ivermectin formulations against COVID-19, the Philippine Council for Health Research and Development (DOST-PCHRD) is...

PGH spox: 'Prudent' to pause use of AstraZeneca vaccine for those under 60 - Vimarsana News

PGH spox: 'Prudent' to pause use of AstraZeneca vaccine for those under 60

endIndex: Metro Manila (CNN Philippines, April 9) — The decision to temporarily stop giving the AstraZeneca vaccine to people under the age of 60 is an act of prudence, Philippine General Hospital spokesman Jonas del Rosario said Friday, adding there is time to pause since most of those who received the first shot won't need the second dose until late May or early June. “I think it is just prudent for the FDA to check on the data,” del Rosario told CNN Philippines’ New Day. “We have time to pause, review the data, check if any of our vaccinees had complication of blood clots,” h...

Elderly may still get AstraZeneca vaccine but stocks depleted —FDA, DOH - Vimarsana News

Elderly may still get AstraZeneca vaccine but stocks depleted —FDA, DOH

Elderly may still get AstraZeneca vaccine but stocks depleted —FDA, DOH By JULIA MARI ORNEDO, GMA News Published April 9, 2021 5:49pm The use of the AstraZeneca may have been temporarily suspended for people younger than 60, but the elderly may still get the British-Swedish jab once the Philippines’ supply is replenished, health authorities said Friday. Food and Drug Administration (FDA) chief Eric Domingo said the rare side effect of blood clotting with low platelet count was most common among women under 60. He explained that individuals above 60 will benefit the most from get...